FLT-3 mutation maybe an inferior predictor of daratumumab therapy in acute myeloid leukemia patients relapsed after allogeneic stem cell transplantation

Int J Lab Hematol. 2024 Apr 10. doi: 10.1111/ijlh.14275. Online ahead of print.NO ABSTRACTPMID:38600651 | DOI:10.1111/ijlh.14275

Source: International Journal of Laboratory Hematology - April 11, 2024 Category: Hematology Authors: Song Xue Wenqiu Huang Yongping Zhang Fuhong Liu Qi Hao Jiajun Hu Lei Yuan Jingbo Wang Source Type: research